AmerisourceBergen Corp (NYSE:ABC) files its latest 10-K with SEC for the fiscal year ended on September 30, 2017. AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada. AmerisourceBergen Corp has a market cap of $17.41 billion; its shares were traded at around $79.46 with a P/E ratio of 42.94 and P/S ratio of 0.11. The dividend yield of AmerisourceBergen Corp stocks is 1.87%. AmerisourceBergen Corp had annual average EBITDA growth of 8.90% over the past ten years. GuruFocus rated AmerisourceBergen Corp the business predictability rank of 3-star.
For the last quarter AmerisourceBergen Corp reported a revenue of $39.1 billion, compared with the revenue of $37.6 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $153.1 billion, an increase of 4.3% from last year. For the last five years AmerisourceBergen Corp had an average revenue growth rate of 15.5% a year.
The reported diluted earnings per share was $1.87 for the year, a decline of 70.4% from the previous year. The AmerisourceBergen Corp had an operating margin of 0.73%, compared with the operating margin of 1.04% a year before. The 10-year historical median operating margin of AmerisourceBergen Corp is 1.11%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, AmerisourceBergen Corp has the cash and cash equivalents of $2.4 billion, compared with $2.7 billion in the previous year. The long term debt was $3.4 billion, compared with $3.9 billion in the previous year. The interest coverage to the debt is 6.4. AmerisourceBergen Corp has a financial strength rank of 6 (out of 10).
At the current stock price of $79.46, AmerisourceBergen Corp is traded at 11.8% discount to its historical median P/S valuation band of $90.14. The P/S ratio of the stock is 0.11, while the historical median P/S ratio is 0.13. The intrinsic value of the stock is $19.80 a share, according to GuruFocus DCF Calculator. The stock lost 0.35% during the past 12 months.
CEO Recent Trades:
Chairman, President & CEO Steven H Collis sold 21,350 shares of ABC stock on 11/01/2017 at the average price of $76.94. The price of the stock has increased by 3.28% since.
CFO Recent Trades:
CFO Tim G. Guttman sold 11,600 shares of ABC stock on 11/03/2017 at the average price of $74.28. The price of the stock has increased by 6.97% since.
Directors and Officers Recent Trades:
Executive Vice President Dale Danilewitz sold 4,459 shares of ABC stock on 11/20/2017 at the average price of $78.3. The price of the stock has increased by 1.48% since.Executive Vice President Dale Danilewitz sold 1,857 shares of ABC stock on 11/13/2017 at the average price of $74.69. The price of the stock has increased by 6.39% since.Executive Vice President Peyton R Howell sold 3,000 shares of ABC stock on 11/08/2017 at the average price of $74.87. The price of the stock has increased by 6.13% since.Executive Vice President John G. Chou sold 15,937 shares of ABC stock on 11/06/2017 at the average price of $74.5. The price of the stock has increased by 6.66% since.Executive Vice President Dale Danilewitz sold 2,012 shares of ABC stock on 11/02/2017 at the average price of $74.99. The price of the stock has increased by 5.96% since.
For the complete 20-year historical financial data of ABC, click here.